Latest News

Amphenol (APH) is back in focus after reporting record Q4 2025 sales of US$6.439b and earnings growth of more than 50%, with AI related data center demand standing out across already broad end market strength. See our latest analysis for Amphenol. The latest special call and shelf registration for new debt securities come after a very strong run, with the share price at US$133.92 and a 1 year total shareholder return of about 114%. However, the 1 month share price return of 7.03% and year to...

Gas supply disruptions in Qatar have led the Qatalum aluminum plant, a major joint venture of Norsk Hydro (OB:NHY), to cut production to 60% capacity. Qatalum avoided a full shutdown after QatarEnergy resumed limited gas supply under an updated agreement. The event directly affects Norsk Hydro’s joint venture income and contributes to tighter global aluminum supply conditions. Norsk Hydro is a fully integrated aluminum company, with Qatalum playing an important role in its global smelting...

If you are wondering whether Mohawk Industries at around US$102.55 is a potential bargain or a value trap, you are not alone. The stock has seen a 24.0% decline over the last 30 days and is down 10.3% over the past year, even though the 3 year return sits at 8.7%. Recent headlines have focused on Mohawk Industries' position in the flooring and broader consumer durables market, including how it is responding to shifts in housing activity and renovation demand. This context has kept attention...

Recent share performance and business snapshot Under Armour (UAA) has had a mixed run recently, with the stock down over the past month but positive over the past 3 months. This may prompt investors to reassess the story. The company generated revenue of about US$4.98b and reported a net loss of roughly US$519.71 million, while long term total returns over 3 and 5 years have been negative. This highlights ongoing turnaround questions. See our latest analysis for Under Armour. At a share price...

Why Medacta Group’s latest earnings matter for shareholders Medacta Group (SWX:MOVE) has just reported its 2025 results, with revenue of €684 million, EBITDA margin at 29%, net profit up 31% year over year, and a proposed dividend of CHF 1.10 per share, almost 60% higher. See our latest analysis for Medacta Group. At a share price of CHF155.8, Medacta’s 5.7% 1 month share price return sits against a modestly positive 3 month move of 3.0% and a much stronger 1 year total shareholder return of...

Event context and recent share performance Hanover Insurance Group (THG) has been on investors’ radar after recent share swings, including a roughly 6% decline over the past 3 months and a small gain over the past month. See our latest analysis for Hanover Insurance Group. At a share price of US$173.39, Hanover Insurance Group’s recent 1 day and 7 day share price declines sit against a modest 1 year total shareholder return of 4.5% and a strong 3 year total shareholder return of 53.4%. This...

In early March 2026, Box, Inc. reported higher quarterly and full-year revenue alongside lower net income, issued new earnings guidance for fiscal 2027, and confirmed it had completed a multi-year share repurchase totaling US$1.28 billion for about a third of its shares. The combination of revenue growth, reduced profitability, and large-scale buybacks gives investors fresh information on how Box is balancing expansion, earnings, and capital returns. Next, we’ll examine how Box’s new revenue...

Butler National (BUKS) has reported Q3 2026 revenue of US$26.9 million and basic EPS of US$0.10, set against trailing twelve month revenue of US$91.9 million and EPS of US$0.30 that came with 44.1% earnings growth and a 21.4% net margin over the past year. The company has seen quarterly revenue move from US$21.2 million in Q3 2025 to US$26.9 million in Q3 2026 and basic EPS from US$0.05 to US$0.10 across the same periods, with trailing net income reaching US$19.7 million, which positions the...

Guidance points to profit to loss swing Star Plus Legend Holdings (SEHK:6683) has guided for a consolidated loss of up to CN¥52.0 million for 2025, compared with a consolidated profit of CN¥50.2 million for 2024. The board links this shift mainly to slower IP content launches affecting its IP creation segment, lower gross margins in the expanding new retail business, and a non cash impairment provision on certain trade receivables tied to recent geopolitical developments. See our latest...

In recent weeks, Vital Farms reported weaker-than-expected quarterly earnings, prompting multiple law firms to launch securities investigations while the stock touched a new 52-week low and sector-wide pressures weighed on sentiment. Amid these legal probes and analyst concerns, Director Karl Khoury’s purchase of 5,000 additional shares stands out as a contrasting insider confidence signal. We’ll now examine how the earnings disappointment and resulting legal investigations might reshape...

Develop Global (ASX:DVP) is back in focus after releasing half year results to December 31, 2025, reporting sales of A$170.53 million and net income of A$1.63 million, both above the prior period. See our latest analysis for Develop Global. That earnings update landed against a weaker near term backdrop, with a 1 day share price return showing a decline of 3.74% and a 30 day share price return showing a decline of 15.66%, while the 1 year total shareholder return of 58.02% points to much...

PDD Holdings recently drew heightened investor attention as analysts raised earnings estimates ahead of its upcoming March 2026 report, while expectations point to solid year-over-year growth in both earnings and revenue. This renewed optimism has emerged even as the company faces ongoing regulatory and data privacy scrutiny in both the U.S. and China, highlighting investors’ focus on its operational performance and global e-commerce positioning. We’ll now examine how this pre-earnings...

Factory closures put Kraft Heinz (KHC) regional footprint under the spotlight Kraft Heinz (KHC) has outlined plans to shut facilities in New Zealand that produce Wattie’s frozen vegetables, Gregg’s coffee, and various dips, an operational shift tied to challenging conditions and recent financial losses. The move, which could affect around 350 jobs, highlights how management is reshaping its regional footprint and raises fresh questions for investors about profitability, efficiency, and long...

In early March 2026, Tenaya Therapeutics reported a narrower full-year 2025 net loss of US$90.6 million and highlighted new preclinical data for TN-301 in Duchenne muscular dystrophy alongside a research collaboration with Alnylam Pharmaceuticals on up to 15 cardiovascular gene targets that could yield as much as US$1.13 billion in milestones. Together, these updates underscore how Tenaya is pairing emerging HDAC6 science in DMD and heart failure with a genetically guided partnership model...

HSBC’s decision to upgrade Millicom International Cellular (TIGO) from Hold to Buy, citing sustained operational execution and stronger cash flow, has put fresh attention on a stock some investors viewed as fully valued. See our latest analysis for Millicom International Cellular. That upgrade comes on the back of a sharp shift in sentiment, with a 38.83% 3 month share price return and a 163.61% 1 year total shareholder return suggesting momentum has been building rather than fading. If this...

Earlier this month, Universal Technical Institute reported that it beat its fiscal 2025 operational targets with double‑digit revenue growth while a director, Shannon Lei Okinaka, sold 10,000 shares, about one‑third of her direct holdings, for roughly US$347,414 in an open‑market transaction on March 6, 2026. These developments come as the company is funding an ambitious multi‑year campus expansion that is compressing near‑term profits but is intended to support higher long‑term revenue and...

Why USA Rare Earth Is On Investors’ Radar USA Rare Earth (USAR) has drawn fresh attention after a recent stretch of mixed share performance, with a decline over the past month alongside a gain over the past 3 months. For investors watching critical minerals, that combination of shorter term weakness and recent quarterly strength may raise questions about how to interpret USA Rare Earth’s current valuation and risk profile. See our latest analysis for USA Rare Earth. At a share price of...

REX American Resources recently saw its market value reach about US$1.30 billion as its shares moved to fresh highs, ahead of reporting fiscal fourth-quarter and full-year 2025 results on 26 March 2026. This momentum comes even after earlier revenue and earnings declines, as higher oil prices renew attention on REX’s ethanol business as an alternative fuel option. Next, we’ll examine how this oil price-driven momentum in REX’s ethanol operations could influence the company’s existing...

In March 2026, a jury in the Western District of Texas found that Lyft's Smart Trip Check-In safety feature infringed Quartz Auto Technologies' U.S. Patent No. 9,460,616 and awarded Quartz Auto a lump-sum damages payment after rejecting Lyft's invalidity arguments. The verdict raises questions about how Lyft may need to adapt or license its real-time ride monitoring technology, which underpins key in-app safety functions for riders and drivers. We'll now examine how this patent...

Upcoming earnings event puts Microvast Holdings (MVST) in focus Microvast Holdings (NasdaqCM:MVST) has set March 16, 2026, after market close, for its full year and fourth quarter 2025 results, followed by a webcast and earnings call that many investors will be watching closely. See our latest analysis for Microvast Holdings. Microvast Holdings' recent 1-day and 7-day share price returns of 2.77% and 7.21% come after a tougher stretch, with a 30-day share price return of an 8.61% decline and...

If you are wondering whether Establishment Labs Holdings at around US$63.35 is still offering value or has already run too far, this article is designed to walk you through that question step by step. The share price has seen a 71.0% return over the past year, even though the stock is down 10.0% over the last week, 12.9% over the last month, and 8.0% year to date. This can change how investors think about both its growth potential and risk. Recent news around Establishment Labs has mainly...

Capricor Therapeutics (CAPR) has just posted its FY 2025 first half results with total revenue of US$0 million and a basic EPS loss of US$1.10, while trailing twelve month revenue sits at US$13.39 million with a basic EPS loss of US$1.66. Over recent periods, the company has reported revenue of US$8.88 million and US$13.39 million across the two halves of FY 2024, alongside basic EPS losses of US$0.66 and US$0.51. This provides context for how current margins remain under pressure. With...

Institutional stake cut puts Applied Industrial Technologies in focus Victory Capital Management Inc. recently cut its stake in Applied Industrial Technologies (AIT) by 45.2% in the third quarter, reducing its position to 86,330 shares from 157,638. This move has drawn fresh attention to the stock. See our latest analysis for Applied Industrial Technologies. At a share price of US$255.65, Applied Industrial Technologies has seen a 1 month share price return of 11.94% decline and a year to...

Why the Stripe partnership matters for Affirm Affirm Holdings (AFRM) is back in focus after expanding its long-running partnership with Stripe to support Shared Payment Tokens, letting AI agents offer Affirm’s pay over time plans directly within AI driven checkout flows. This move plugs Affirm’s financing options into Stripe powered agentic commerce, so shoppers can authorize AI agents to complete purchases using Affirm while merchants process those payments on the backend through Stripe. See...